Spero Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2021 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Spero Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2021 to 2023.
  • Spero Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 54M shares, a 2.64% increase year-over-year.
  • Spero Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 52.7M shares, a 40.2% increase from 2022.
  • Spero Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 37.6M shares, a 21.7% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 52.7M +15.1M +40.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 37.6M +6.69M +21.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 30.9M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.